Please assess the completion status of the following clinical trial:

Trial Title: Low Energy Therapy to Convert Ventricular Tachycardias

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with a history of ventricular tachycardia indicated for ventricular testing procedures that may include VT induction, such as VT testing, VT ablation, VT mapping, or VT risk stratification testing.~* Subjects age 18 or above, or of legal age to give written informed consent specific to local laws and requirements~* Subjects who, in the opinion of the investigator, are suitable to be enrolled in a clinical study~Exclusion Criteria:~* Subjects with any comorbidities that, in the opinion of the investigator, would exclude them from standard of care VT testing~* Subjects with VT that is known to be focal in nature~* Subjects whom the investigator believes are not hemodynamically stable enough to tolerate testing~* Subjects of childbearing age who may be pregnant.~* Subjects who are unwilling or unable to provide written informed consent.~* Subjects with any implanted device that emits electrical energy where either therapy cannot be temporarily disabled, or the subject cannot tolerate temporary disabling of therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Acute Testing (Type: EXPERIMENTAL): Single-arm study - all subjects who meet the I\&E criteria, sign the consent form and have inducible VT within the protocol-specified criteria may be tested for VT conversion with the LEVER Acute Study System.

Based on this trial design, predict the completion outcome and termination type (if applicable).